Plant Advanced Technologies SA (EPA:ALPAT)
6.75
0.00 (0.00%)
Jul 14, 2026, 9:00 AM CET
EPA:ALPAT Revenue
In the year 2025, Plant Advanced Technologies had annual revenue of 1.65M EUR, down -25.50%. Plant Advanced Technologies had revenue of 1.26M in the half year ending December 31, 2025, a decrease of -50.80%.
Revenue
1.65M
Revenue Growth
+26.50%
P/S Ratio
4.60
Revenue / Employee
150.02K
Employees
11
Market Cap
7.59M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.65M | -564.97K | -25.50% |
| Dec 31, 2024 | 2.22M | 4.59K | 0.21% |
| Dec 31, 2023 | 2.21M | 68.51K | 3.20% |
| Dec 31, 2022 | 2.14M | -162.96K | -7.07% |
| Dec 31, 2021 | 2.31M | -1.14M | -32.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| genOway Société anonyme | 28.60M |
| Nicox | 16.77M |
| Poxel | 7.66M |
| Advicenne | 6.40M |
| Aelis Farma | 2.08M |
| Oncodesign Precision Medicine Société anonyme | 1.81M |
| Aton | 656.93K |
| GenSight Biologics | 652.00K |